openPR Logo
Press release

Long Acting Drug Delivery Market Trend Report 2022-2031 by Top Area - Neurology, Oncology, Cardiovascular, Gastric, Ophthalmology

11-08-2022 06:51 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Long Acting Drug Delivery Market is slated to witness exponentiation going forward. The IoMT (Internet-of-Medical-Things) is already transforming every walk of life, including healthcare. Healthcare IT has let both - patients and doctors carry/download information about each other anywhere and anytime through their smartphones/tabs. In other words, more connectivity translates to better access to data, thereby rendering better healthcare for patients. This would be the future of the healthcare vertical in the upcoming period.

According to the latest research by PMR, long acting drug delivery systems are set to witness a steady-paced growth of CAGR 6.4% during the year 2021-2031.

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders.

Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32863

The long acting drug delivery industry is expected to witness a rise in demand over the forecast period owing to the increasing technological advancements in clinical and pharmaceutical research globally.

The long acting drug delivery systems, such as implants and injectables are responsible for a controlled delivery of API in the patient's body. This is a major driving factor for the adoption of long acting drug delivery systems, as they reduce the burden of compliance on the patients, as compared to frequent dosing associated with traditional pills or injections.

The long acting drug delivery also reduces the metabolic degradation of the active pharmaceutical products by delivering targeted drug dosage directly into the environment or the bloodstream. The efficiency of such systems is thus responsible for driving the growth of long acting drug delivery systems worldwide.

Apart from great therapeutic effects of long acting drug delivery, the main augmentative factor in this industry is the increasing value of reformulated active pharmaceutical ingredients. The key players in the industry focus on patented formulations with specified dosage forms for the therapeutic treatment of several chronic diseases.

The increasing revenue as well as a unique stance in the market over the other players has led to intensive research through competition. Companies benefit from novel formulations because of their high revenue potential. This is set to augment the growth and development of long acting drug delivery systems over the forecast period.

The region of North America is expected to grow pose a dominant stance over the forecast period in terms of revenue share of long acting drug delivery systems. The factors aiding this growth are the presence of high profile, key players in the region, such as Lubrizol Life Science in the U.S., and innovation and development of new drug formulations.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32863

Additionally, many companies in this region are involved in strategic partnerships for enhancement of their product portfolios through research and development activities. For instance, in June 2021, ViiV Healthcare and Halozyme Therapeutics entered a global partnership and licence agreement to leverage the latter's ENHANZE drug delivery technology to develop 'ultra long-acting' drugs for human immunodeficiency virus (HIV).

The European region is expected to witness an increasing demand for long acting drug delivery systems. This is owed by the rising adoption of studies assessing the efficiency of these systems for their therapeutic effects.

For instance, long acting drug delivery implants, such as the thermoplastic polyurethanes (TPU), is used in an approved vaginal ring in Europe. It offers high levels of customization and control over drug release, creating possibilities for more efficient vaginal ring and implant designs.

The key companies operating in manufacturing and supply of long acting drug delivery systems are,

ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences Inc.
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Zordera
Creative Biolabs.

Key Segments

By Therapies

Device
Implant
Vaginal rings
Microarray patch
Gastric resident device
Parenteral Injections
Monoclonal antibody
Polymer microsphere
In-situ forming gel
Oil depot
Aqueous dispersion
By Therapeutic Area

Neurology
Oncology
Cardiovascular
Gastric
Ophthalmology
Others
By Distribution Channel

Hospital Pharmacies
Institutional Sales
Retail Sales
Clinical Research Institutes
Online Distribution Channels

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32863

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long Acting Drug Delivery Market Trend Report 2022-2031 by Top Area - Neurology, Oncology, Cardiovascular, Gastric, Ophthalmology here

News-ID: 2796341 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Therapeutic

Exosome Therapeutic Market : Detailed Overview
Introduction: The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028. Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market. Browse 147 Market Data Tables and 115
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The